Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.

Sullivan, SDSDSullivanVeenstra, DLDLVeenstraChen, PJPJChenChang, TTTTChangChuang, WLWLChuangTsai, CCTsaiPatel, K.K.Patel2010-10-222018-07-062010-10-222018-07-062007-09http://ntur.lib.ntu.edu.tw//handle/246246/218943en-US[SDGs]SDG3Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.